

Newcomer Pod
Eric Newcomer | newcomer.co
Join Eric Newcomer, Tom Dotan, and Madeline Renbarger to get the inside story on the biggest news in Tech, Silicon Valley, and Venture Capital.
Episodes
Mentioned books

60 snips
Nov 17, 2025 • 46min
Inside Anthropic’s Plan to Fix AI’s BIGGEST Problem
Mike Krieger, Chief Product Officer at Anthropic, discusses the need for truth-seeking AI to combat misinformation, emphasizing the importance of quality over quantity in outputs. He explains how structured prompts improve AI interactions. Mati Staniszewski, CEO of ElevenLabs, shares insights into the future of voice AI, highlighting its role in customer support and integration with real-world systems. They delve into safety measures for licensed voices and the importance of authenticity in voice technology, all while tackling challenges like deepfakes.

12 snips
Nov 10, 2025 • 33min
AI Predicts Its Own Rise (and Fall)
What if AI could predict its own future? The hosts delve into predictions made by AI about its own evolution over five years. They analyze the accuracy of past forecasts, from political ad disclosures to ambitious targets for AI-generated music topping charts. Discussions include AI's role in healthcare and the possibility of AI-driven scientific research. Interesting debates arise on everything from Apple acquisitions to real-time generative features in video games, questioning whether AI's self-expectations hold any weight.

63 snips
Oct 31, 2025 • 1h 10min
Inside the AI Gold Rush (One Year Later)
Explore the shifting landscape of AI investment and the unexpected challenges of widespread agent deployment. Discover the emerging appetite for AI-generated content and the potential mental health implications of AI-driven experiences. Delve into the ongoing debate about whether the AI boom is a bubble or a sustainable growth phase. Get insights on the latest from the Annual AI Fantasy Draft, where the hosts reveal their strategic bets on promising AI startups and highlight dynamic shifts in developer workflows.

Oct 30, 2025 • 53min
Inside Amazon’s $100B Automation Gamble
The hosts dive into the hype surrounding AI and its potential peak. They explore Andreessen Horowitz's record cash returns and how Amazon's automation could threaten jobs. A critique of AI’s real progress reveals worries about an impending bubble. The conversation touches on the disparity between the promises of agent startups and their real-world utility. They also discuss the cultural impacts of AI-generated content and the critical role of unions amid automation's rise.

12 snips
Oct 10, 2025 • 36min
Inside the $Trillion AI Money Machine
AI stocks are skyrocketing, but are we nearing a breaking point? The discussion dives into how companies like OpenAI and Nvidia are creating a massive tech money machine reminiscent of the dot-com bubble. There's chatter about the intertwined relationship between OpenAI and Nvidia, and how brand activations like Anthropic's Claude pop-up in New York could reshape user engagement. As big moves and partnerships inflate valuations, questions arise about sustainability and whether this AI economy might be a Ponzi scheme in disguise.

64 snips
Oct 3, 2025 • 52min
The Coming AI Crash No One Wants to Admit | Alex Heath x Newcomer Podcast
In this discussion, tech journalist Alex Heath dives deep into the looming concerns regarding the AI bubble. He explains how OpenAI’s partnerships impact major players like Microsoft and Oracle while addressing the potential for systemic risks in the market. The conversation shifts to Meta's quirky launch of Vibes and its implications for the AI hype cycle. Alex also highlights the role of data-driven ads as a necessary revenue engine for AI ventures and the tensions in labs balancing AGI ambitions with consumer needs.

23 snips
Sep 26, 2025 • 44min
Andreessen Horowitz’s Media Empire, Trump vs. Kimmel, Klarna’s $15B IPO Lessons
In this conversation, Madeline Renbarger, a tech and finance reporter, shares insights on the Klarna IPO, revealing key winners and losers, along with lessons for investors. Tom Dotan, a cultural commentator, discusses the fallout of the Jimmy Kimmel controversy and examines how corporate dynamics shape media narratives. They dive into Andreessen Horowitz’s media strategy, highlighting its ambition to influence tech narratives and explore the intersection of politics and entertainment. It's a lively discussion about power, media, and investment!

12 snips
Sep 19, 2025 • 36min
AI, Longevity, and the Health Revolution with Nayeema Raza
A pivotal shift in public health is underway, driven by billionaires in pursuit of immortality and the rapid integration of AI in healthcare. The discussion highlights troubling aspects of the American healthcare system and the excitement surrounding GLP-1 drugs. Insights from a recent summit showcase how China is advancing human trials faster than the U.S. The conversation raises critical questions about the future of patient privacy and the potential misuse of AI by insurers, all while exploring the balance between technological advancement and ethical considerations.

29 snips
Sep 12, 2025 • 43min
From Deus Ex Medicina: Vinod Khosla, Bob Kocher & Annie Lamont
Annie Lamont, Founder of Oak HC/FT, and Bob Kocher, Partner at Venrock, discuss innovative business models in healthcare and the rise of AI applications, along with the future of Medicare Advantage. Vinod Khosla, Founder of Khosla Ventures, weighs in on AI's transformative role, regulatory hurdles, and the challenge of global competition. They also explore the promise of GLP-1 longevity drugs, the impact of telehealth, and how startups can reshape the entire healthcare landscape.

20 snips
Sep 5, 2025 • 29min
The Stakes at Deus Ex Medicina
Nayeema Raza, a journalist and host of Smart Girl, Dumb Questions, teams up with Eric Newcomer to discuss their upcoming AI health summit, Deus Ex Medicina. They tackle how longevity has gone mainstream, the real impact of precision medicine, and the intriguing question of who controls patient data. The duo dives into D.C. policy shifts affecting healthcare, the potential of AI to discover new drugs, and their excitement for live discussions at the summit, hinting at the convergence of technology and healthcare.


